Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
K25MgZCMFLDTsdac
Listen
